Skip to main content

Shamrock Structures Lands VC Funding to Market Argonne Proteomics Technology

NEW YORK, Nov. 4 (GenomeWeb News) - Shamrock Structures, a Chicago-based structural proteomics startup, has secured an undisclosed amount of funding from early-stage venture capital firm Flavin Ventures, the company said today.

Shamrock Structures will offer services in structural proteomics - such as protein cloning, expression, purification, and crystallization -- via a special arrangement with Argonne National Laboratory that provides access to the Advanced Photon Source synchrotron.   

"Our agreement with Shamrock Structures will allow us to more easily deliver Argonne's powerful structural proteomics technologies to the marketplace," said Andrej Joachimiak, head of the Structural Biology Center at Argonne National Laboratory.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.